据报内地第三轮药品集中采购将於两个月内举行
据《中国证券报》报道,内地由国家医保局组织的第三轮带量采购行动将於两个月内举行,参与集采的区域为全国32个省(区、市)的公立医院,药品品种数量为35个,其中不少属於高血压、糖尿病这两类慢性病的用药。本轮带量采购方案将调整部分规则,例如中标的生产厂商最多可达6间。
中标原则方面,仍然采用最低价中标的方式,允许多间企业中标。中标企业的数量为n-1,例如7间投标,6间中标。另外,在报价上采用淘汰制,一旦企业的报价超过最低价的1.8倍,将直接出局。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.